|
CLPX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.03614902716254E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.21458398893992E-13 |
| Normal-vs-Stage2 |
1.771150E-04 |
| Normal-vs-Stage3 |
6.15389999999438E-05 |
| Normal-vs-Stage4 |
3.72340000054372E-07 |
| Stage1-vs-Stage2 |
4.822600E-01 |
| Stage1-vs-Stage3 |
4.641200E-01 |
| Stage1-vs-Stage4 |
7.438600E-01 |
| Stage2-vs-Stage3 |
9.622200E-01 |
| Stage2-vs-Stage4 |
3.957000E-01 |
| Stage3-vs-Stage4 |
4.495600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.28466159721575E-14 |
| Normal-vs-AfricanAmerican |
2.87320000014191E-08 |
| Normal-vs-Asian |
1.991830E-01 |
| Caucasian-vs-AfricanAmerican |
3.340000E-01 |
| Caucasian-vs-Asian |
5.856600E-01 |
| AfricanAmerican-vs-Asian |
8.454800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62847513252018E-12 |
| Normal-vs-Female |
4.53199999994602E-06 |
| Male-vs-Female |
1.195570E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.71389999987271E-07 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
1.55279999969338E-09 |
| Normal-vs-Extreme_Obese |
6.347600E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.136190E-01 |
| Normal_Weight-vs-Obese |
8.150800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.111600E-01 |
| Extreme_Weight-vs-Obese |
1.436260E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.060400E-01 |
| Obese-vs-Extreme_Obese |
7.535200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.000500E-04 |
| Normal-vs-Age(41-60Yrs) |
5.86652948442179E-12 |
| Normal-vs-Age(61-80Yrs) |
5.07704989161084E-13 |
| Normal-vs-Age(81-100Yrs) |
3.405500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.168200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.111000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.933400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.332200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.421200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.710400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.33066907387547E-15 |
| Normal-VS-Type2 PRCC |
1.61509999996312E-06 |
| Normal-VS-KIRP CIMP |
5.81490000040041E-07 |
| Normal-VS-Unclassified PRCC |
4.43199999999866E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.662000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.834600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.787030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.472600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.978800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.625600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.2646994562715E-10 |
| Normal-vs-N1 |
2.496900E-03 |
| Normal-vs-N2 |
9.20029999962324E-08 |
| N0-vs-N1 |
7.120400E-02 |
| N0-vs-N2 |
1.969170E-01 |
| N1-vs-N2 |
5.066300E-02 |
|
|
